Regulation by GD3 of the proinflammatory response of microglia mediated by interleukin-15

Journal of Neuroscience Research

Volumn 83, Issue 5, 2006, Pages 754-762

  Gómez Nicola, Diego ^a   Doncel Pérez, Ernesto ^b   Nieto Sampedro, Manuel ^a,b  

^a CSIC   (Spain)

^b HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

Author keywords

CNS; Cytokines; Gangliosides; Neuropathic pain

Indexed keywords

CYTOKINE; GANGLIOSIDE GD3; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 15 RECEPTOR ALPHA; MESSENGER RNA; NITRIC OXIDE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; BRAIN DAMAGE; BRAIN INJURY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EVOLUTION; HOMEOSTASIS; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MICROGLIA; MOUSE; NERVE CELL CULTURE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY;

ANIMALS; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIOSIDES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-15; LYMPHOCYTE ACTIVATION; MICE; MICROGLIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 33645291763     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20777     Document Type: Article

References (63)

1. Abad-Rodríguez J, Bernabé M, Romero-Ramírez L, Vallejo-Cremades M, Fernández-Mayoralas A, Nieto-Sampedro M. 2000. Purification and structure of neurostatin, an inhibitor of astrocyte division of mammalian brain. J Neurochem 74:2547-2556.
2. Aloisi F. 2001. Immune function of microglia. Glia 36:165-179.
3. Armitage RJ, Macduff BM, Eisenmann J, Paxton R, Grabstein KH. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J immunol 154:483-490.
4. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290.
5. Baeuerle PA, Henkel T. 1994. Function and activation on NF-κB in the immune system. Annu Rev Immunol 12:141-179.
6. Barnes PJ, Adcock IM. 1997. NF-κB: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci 18:46-50.
7. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
8. Byrne MC, Farooq M, Sbaschnig-Agler M, Norton WT, Ledeen RW. 1988. Ganglioside content of astroglia and neurons isolated from maturing rat brain: consideration of the source of astroglial gangliosides. Brain Res 461:87-97.
9. Caetano MS, Vieira-de-Abreu A, Teixeira LK, Werneck MB, Barcinski MA, Viola JP. 2002. NFATC2 transcription actor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB J 16:1940-1942.
10. Cammer W, Zhang H. 1996. Ganglioside GD3 in radial glia and astrocytes in situ in brains of young and adult mice. J Neurosci Res 46:18-23.
11. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395-1403.
12. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J Clin Invest 96:2578-2582.
13. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J immunol 149:2736-2741.
14. Chu WK, Sharom FJ. 1993. Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptors. Immunology 79:10-17.
15. Doherty TM, Seder RA, Sher A. 1996. Induction and regulation of IL-15 expression in murine macrophages. J Immunol 156:735-741.
16. Dubois S, Magrangeas F, Lehours P, Raher S, Bernard J, Boisteau O, Leroy S, Minvielle S, Godard A, Jacques Y. 1999. Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression. J Biol Chem 274:26978-26984.
17. Eicher DM. 2003. IL-2 and IL-15 manifest opposing effects on activation of nuclear factor of activated T cells. Cell Immunol 223:133-142.
18. Ellison JA, de Vellis J. 1995. Amoeboid microglia expressing GD3 ganglioside are concentrated in regions of oligodendrogenesis during development of the rat corpus callosum. Glia 14:123-132.
19. Giri J, Kumaki S, Ahdie M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM. 1995. Identification and clonig of a novel IL-15 binding protein that is structurally related to the α-chain of the IL-2 receptor. EMBO J 14:3654-3663.
20. Giron-Michel J, Caignard A, Fogli M, Brouty-Boye D, Briard D, van Dijk M, Meazza R, Ferrini S, Lebousse-Kerdiles C, Clay D, Bompais H, Chouaib S, Peault B, Azzarone B. 2003. Differential STAT3, STAT5, and NF-kappaB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules. Blood 102:109-117.
21. Giulian D, Baker TJ. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163-2178.
22. Goldman JE, Reynolds R. 1996. A reappraisal of ganglioside GD3 expression in the CNS. Glia 16:291-295.
23. Grabstein KH, Eisenmann J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenbom MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG. 1994. Cloning of a T cell growth factor that interacts with β-chain of the interleukin-2 receptor. Science 264:965-968.
24. Hamilton WB, Helling F, Lloyd KO, Livingstone PO. 1993. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography. Int J Cancer 53:566-573.
25. Hanisch U, Quirion R. 1996. Interleukin-2 as a neuroregulatory cytokine. Brain Res Rev 21:246-284.
26. Hanisch UK, Lyons SA, Prinz M, Nolte C, Weber JR, Kettenmann H, Kirchhoff F. 1997. Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J Biol Chem 272:28853-28860.
27. Heyen JRR, Ye S, Finck BN, Johnson RW. 2000. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation on NF-κB. Brain Res Mol Brain Res 77:138-147.
28. Hoon DS, Irie RF, Cochran AJ. 1988. Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2. Cell Immunol 111:410-419.
29. Hu P, McLachlan EM. 2002. Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience 112:23-38.
30. Irani DN, Lin KI, Griffin DE. 1996. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J Immunol 157:4333-4340.
31. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA. 1994. Constitutive NF-kappa B activity in neurons. Mol Cell Biol 14:3981-3992.
32. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
33. Lee YB, Satoh JI, Walker DG, Kim SU. 1996. Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport 7:1062-1066.
34. Marchand F, Perretti M, McMahon SB. 2005. Role of the immune system in chronic pain. Nat Rev Neurosci 6:521-532.
35. McDonald PP, Russo MP, Ferrini S, Cassatella MA. 1998. Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils. Blood 92:4828-4835.
36. Molotkovskaya IM, Kholodenko RV, Molotkovsky JG. 2002. Influence of gangliosides on the IL-2- and IL-4-dependent cell proliferation. Neurochem Res 27:761-770.
37. Morioka N, Furue M, Tsuchida T, Ishibashi Y. 1991. Gangliosides inhibit the proliferation of human T cells stimulated with interleukin-4 or interleukin-2. J Dermatol 18:447-453.
38. Moutoussamy S, Kelly PA, Finidori J. 1998. Growth-hormone-receptor and cytokine-receptor-family signaling. Eur J Biochem 255:1-11.
39. Nieto-Sampedro M. 1988. Astrocyte mitogen inhibitor related to epidermal growth factor receptor. Science 240:1784-1786.
40. Nieto-Sampedro M, Chandy KG. 1987. Interleukin-2-like activity in injured rat brain. Neurochem Res 12:723-727.
41. Nishimura H, Yajima T, Naiki Y, Tsunobuchi H, Umemura M, Itano K, Matsuguchi T, Suzuki M, Ohashi PS, Yoshikai Y. 2000. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med 191:157-170.
42. O'Neil LAJ, Kaltschmidt C. 1997. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252-258.
43. Parker J, Calami G, Krishnamurti C, Ahrens PB, Ankel H. 1984. Binding of interleukin 2 to gangliosides. FEBS Lett 170:391-395.
44. Pereno R, Giron-Michel J, Gaggero A, Cazes E, Meazza R, Monetti M, Monaco E, Mishal Z, Jasmin C, Indiveri F, Ferrini S, Azzarone B. 2000. IL-15/IL-15Ralpha intracellular trafficking in human melanoma cells and signal transduction through the IL-15Ralpha. Oncogene 19:5153-5162.
45. Raivich G, Banati R. 2004. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Brain Res Rev 46:261-281.
46. Rao A. 1994. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol Today 15:274-281.
47. Ravindranath MH, Gonzales A, Soh D, Nishimoto K, Tam W, Bilchik A, Morton DL, O'Day S. 2001. Interleukin-2 binds to ganglioside GD1b. Biochem Biophys Res Commun 283:369-373.
48. Rigui M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani A, Donini SD, Ricciardi-Castagnoli P. 1989. Monokine production by microglial cell clones. Eur J Immunol 19:1443-1448.
49. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers [computer program]. In: Krawetz S, Misener S. Bioinformatics methods and protocols: methods in molecular biology. Totowa, NJ: Humana Press. p 365-386.
50. Satoh J, Kim SU. 1995. Ganglioside markers GD3, GD2, and A2B5 in fetal human neurons and glial cells in culture. Dev Neurosci 17:137-148.
51. Satoh J, Kurohara K, Yukitake M, Kuroda Y. 1998. Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues. J Neurol Sci 155:170-177.
52. Saura J, Tusell JM, Serratosa J. 2003. High-yield isolation of murine microglia by mild trypsinization. Glia 44:183-189.
53. Sawada M, Kondo N, Suzumura A, Marunouchi T. 1989. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 491:394-397.
54. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. 1995. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
55. Simon BM, Malisan F, Testi R, Nicotera P, Leist M. 2002. Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ 9:758-767.
56. Smith KA. 1992. Interleukin-2. Curr Opin Immunol 4:271-276.
57. Sugiyama E, Hara A, Uemura K, Taketomi T. 1997. Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction to ganglioside analyses. Glycobiology 7:719-724.
58. Tagaya Y, Kurys G, Thies TA, Losi JM, Azimi N, Hanover JA, Bamford RN, Waldmann TA. 1997. Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci U S A 94:14444-14449.
59. Tettamanti G, Bonali F, Marchesini S, Zambotti V. 1973. A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta 296:160-170.
60. Wang J, Campbell IL. 2002. Cytokine signaling in the brain: putting a SOCS in it? J Neurosci Res 67:423-427.
61. Washizu J, Nishimura H, Nakamura N, Nimura Y, Yoshikai Y. 1998. The NF-kappaB binding site is essential for transcriptional activation of the IL-15 gene. Immunogenetics 48:1-7.
62. Watkins LR, Maier SF. 2002. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82:981-1011.
63. Wormald S, Hilton D. 2004. Inhibitors of cytokine signal transduction. J Biol Chem 279:821-824.